Allergy Therapeutics plc (AIM:AGY)
London · Delayed Price · Currency is GBP · Price in GBX 5.40
-0.58 (-9.70%)
Jul 27, 2026, 4:35 PM GMT
Allergy Therapeutics Market Cap
Allergy Therapeutics has a market cap or net worth of 341.96 million as of July 27, 2026. Its market cap has decreased by -10.32% in one year.
Market Cap
341.96M
Enterprise Value
358.62M
Revenue
57.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.40
ChartMarket Cap Chart
Since October 11, 2004, Allergy Therapeutics's market cap has increased from 30.57M to 341.96M, an increase of 1,018.62%. That is a compound annual growth rate of 11.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 341.96M | -49.38% |
| Dec 31, 2025 | 675.56M | 118.05% |
| Dec 31, 2024 | 309.82M | 160.00% |
| Dec 29, 2023 | 119.16M | 180.75% |
| Dec 30, 2022 | 42.44M | -79.49% |
| Dec 31, 2021 | 206.98M | 94.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Haleon | 32.02B |
| Hikma Pharmaceuticals | 3.33B |
| HUTCHMED (China) | 1.43B |
| Animalcare Group | 230.27M |
| Venture Life Group | 84.67M |
| ECO Animal Health Group | 68.44M |
| Shield Therapeutics | 65.71M |
| Provexis | 28.03M |